Diagnostic value of follistatin gene mutations in women with polycystic ovary syndrome

被引:0
|
作者
Zia, Sadia [1 ]
Mushtaq, Maham [1 ]
Saleem, Mushtaq Ahmed [1 ]
机构
[1] Univ Cent Punjab, Lahore, Pakistan
来源
RAWAL MEDICAL JOURNAL | 2019年 / 44卷 / 04期
关键词
Mutation; Follistatin gene; polycystic ovary syndrome; hyperandrogenism; ANTI-MULLERIAN HORMONE; ANDROGEN RECEPTOR; HYPERANDROGENISM; INFERTILITY; VARIANTS; FEATURES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is consider as the most common endocrine disorder in women of reproductive age. Strong evidence for a link between the follistatin gene and PCOS has been found in different studies.Follistatin binds to activin and affects its functions, secretion, and stimulation of FSH synthesis (follicle-stimulating hormone). It plays an important role in the functional impairment of the FSH-granulosa cell axis in PCOS. Gene implicated in ovarian follicular development may have a role in the etiology of PCOS, as demonstrated by the identification of the follistatin gene as a potential disease locus. It seems unlikely that PCOS can be explained based on single-gene disorder. One gene may have a predominant effect. Follistatin has been reported as a candidate gene for PCOS for linkage and associated studies. The objective of this review is to define the linkage between PCOS and the follistatin gene and the diagnostic value of PCOS.
引用
收藏
页码:875 / 879
页数:5
相关论文
共 50 条
  • [31] No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome
    Oksanen, L
    Tiitinen, A
    Kaprio, J
    Koistinen, HA
    Karonen, SL
    Kontula, K
    MOLECULAR HUMAN REPRODUCTION, 2000, 6 (10) : 873 - 876
  • [32] CYP21A2 Mutations in Women with Polycystic Ovary Syndrome (PCOS)
    Settas, N.
    Dracopoulou-Vabouli, M.
    Dastamani, A.
    Katsikis, I.
    Chrousos, G.
    Panidis, D.
    Dacou-Voutetakis, C.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (05) : 383 - 386
  • [33] Metabolic syndrome in women with polycystic ovary syndrome
    Chandrasekaran, Swaramya
    Sagili, Haritha
    OBSTETRICIAN & GYNAECOLOGIST, 2018, 20 (04): : 245 - 252
  • [34] Metabolic syndrome in women with polycystic ovary syndrome
    Essah, Paulina A.
    Nestler, John E.
    FERTILITY AND STERILITY, 2006, 86 : S18 - S19
  • [35] Menopause in women with polycystic ovary syndrome
    Grzechocinska, Barbara
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2005, 4 (02): : 34 - 37
  • [36] Sexuality in women with polycystic ovary syndrome
    Kowalczyk, Robert
    Skrzypulec-Plinta, Violetta
    Nowosielski, Krzysztof
    Lew-Starowicz, Zbigniew
    GINEKOLOGIA POLSKA, 2015, 86 (02) : 100 - 106
  • [37] Adropin in women with polycystic ovary syndrome
    Kuliczkowska-Plaksej, Justyna
    Mierzwicka, Agata
    Jonczyk, Maja
    Stachowska, Barbara
    Urbanovych, Alina
    Bolanowski, Marek
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (02) : 151 - 156
  • [38] Homocysteinemia in polycystic ovary syndrome women
    Cleto Cerqueira, Joeline Maria
    Bregieiro Fernandes Costa, Laura Olinda
    Vasconcelos Nogueira, Andrea de Almeida
    Catao da Silva, Daniela Celestino
    Cipriano Torres, Dilenia de Oliveira
    Oliveira dos Santos, Ana Celia
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2010, 32 (03): : 126 - 132
  • [39] Polycystic ovary syndrome in Asian women
    Ng, Ernest Hung Yu
    Ho, Pak Chung
    SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (01) : 14 - 21
  • [40] Adiponectin in Women with Polycystic Ovary Syndrome
    Shin, Hyun-Young
    Lee, Duk-Chul
    Lee, Ji-Won
    KOREAN JOURNAL OF FAMILY MEDICINE, 2011, 32 (04): : 243 - 248